CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling (original) (raw)

• Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC et al. (2007). Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201–209.
  Article CAS Google Scholar
• Biswas S, Criswell TL, Wang SE, Arteaga CL . (2006). Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy. Clin Cancer Res 12: 4142–4146.
  Article CAS Google Scholar
• Chen H, Pimienta G, Gu Y, Sun X, Hu J, Kim MS et al. (2010). Proteomic characterization of Her2/neu-overexpressing breast cancer cells. Proteomics 10: 3800–3810.
  Article CAS Google Scholar
• Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B et al. (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138: 1083–1095.
  Article CAS Google Scholar
• Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL et al. (2006). Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339–9344.
  Article CAS Google Scholar
• Desgrosellier JS, Cheresh DA . (2010). Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10: 9–22.
  Article CAS Google Scholar
• Galliher AJ, Schiemann WP . (2006). Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 8: R42.
  Article Google Scholar
• Galliher AJ, Schiemann WP . (2007). Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67: 3752–3758.
  Article CAS Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555–567.
  Article CAS Google Scholar
• Gu Y, Fu J, Lo P, Wang S, Wang Q, Chen H . (2011). The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres. J Biotech Res 3: 7–18.
  CAS Google Scholar
• Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578–10582.
  Article CAS Google Scholar
• Hanker L, Karn T, Ruckhaeberle E, Gaetje R, Solbach C, Schmidt M et al. (2010). Clinical relevance of the putative stem cell marker p63 in breast cancer. Breast Cancer Res Treat 122: 765–775.
  Article CAS Google Scholar
• Hynes NE, Jaggi R, Kozma SC, Ball R, Muellener D, Wetherall NT et al. (1985). New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line. Mol Cell Biol 5: 268–272.
  Article CAS Google Scholar
• Ishikawa T, Nakagawa H . (2009). Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics. J Exp Ther Oncol 8: 5–24.
  CAS PubMed Google Scholar
• James D, Levine AJ, Besser D, Hemmati-Brivanlou A . (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273–1282.
  Article CAS Google Scholar
• Kalluri R, Weinberg RA . (2009). The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420–1428.
  Article CAS Google Scholar
• Korkaya H, Paulson A, Iovino F, Wicha MS . (2008). HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27: 6120–6130.
  Article CAS Google Scholar
• Kveiborg M, Flyvbjerg A, Eriksen EF, Kassem M . (2001). Transforming growth factor-beta1 stimulates the production of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in human bone marrow stromal osteoblast progenitors. J Endocrinol 169: 549–561.
  Article CAS Google Scholar
• Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF et al. (2008). Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672–679.
  Article CAS Google Scholar
• Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH et al. (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907–913.
  Article CAS Google Scholar
• Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F et al. (2010). Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 12: R21.
  Article Google Scholar
• Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E . (2007). Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 67: 8671–8681.
  Article CAS Google Scholar
• Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW et al. (2006). Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063–6071.
  Article CAS Google Scholar
• Magnifico A, Albano L, Campaner S, Delia D, Castiglioni F, Gasparini P et al. (2009). Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin Cancer Res 15: 2010–2021.
  Article CAS Google Scholar
• Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704–715.
  Article CAS Google Scholar
• Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N et al. (2007). Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 104: 10069–10074.
  Article CAS Google Scholar
• Margadant C, Sonnenberg A . (2010). Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11: 97–105.
  Article CAS Google Scholar
• Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS et al. (2003). Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22: 4314–4332.
  Article CAS Google Scholar
• Scaffidi AK, Petrovic N, Moodley YP, Fogel-Petrovic M, Kroeger KM, Seeber RM et al. (2004). alpha(v)beta(3) Integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts. J Biol Chem 279: 37726–37733.
  Article CAS Google Scholar
• Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML et al. (2006). Generation of a functional mammary gland from a single stem cell. Nature 439: 84–88.
  Article CAS Google Scholar
• Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J et al. (2007). Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259–273.
  Article CAS Google Scholar
• Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D et al. (2006). Purification and unique properties of mammary epithelial stem cells. Nature 439: 993–997.
  Article CAS Google Scholar
• Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE . (2008). The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 68: 7711–7717.
  Article CAS Google Scholar
• Visvader JE . (2011). Cells of origin in cancer. Nature 469: 314–322.
  Article CAS Google Scholar
• Welm B, Behbod F, Goodell MA, Rosen JM . (2003). Isolation and characterization of functional mammary gland stem cells. Cell Prolif 36(Suppl 1): 17–32.
  Article CAS Google Scholar
• Wipff PJ, Rifkin DB, Meister JJ, Hinz B . (2007). Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 179: 1311–1323.
  Article CAS Google Scholar
• Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L . (2008). Brca1 breast tumors contain distinct CD44+/CD24− and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10.
  Article Google Scholar
• Yang C, Patel K, Harding P, Sorokin A, Glass II WF . (2007). Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells. Exp Cell Res 313: 1240–1250.
  Article CAS Google Scholar